Genialis and Debiopharm Set Up Biomarker Discovery Collaboration
Agreement allows both companies to define biomarkers within the [...]
Professional grade software — a key ingredient in cutting edge biomedical discovery | TPM podcast #34
Welcome to Talking Precision Medicine (TPM podcast) — the [...]
Normalizing RNA-seq data in Python with RNAnorm
RNA sequencing (RNA-seq) is a workhorse method for quantifying [...]
Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in triple negative breast cancer patients
Abstract:This study investigates the prevalence of genomic alterations in [...]
Genialis Expands into Triple-Negative Breast Cancer Research: Insights from SABCS 2023
Breast cancer remains a challenging therapeutic area in oncology, [...]
Genialis a Winner in Inc.’s 2023 Best in Business Awards in AI & Data
To build a great company, and a great business, [...]
RNA Biomarkers in Focus: Key Takeaways from SITC and ESMO
Genialis recently took part in two pivotal conferences in [...]
Genialis Presents Data at SITC 2023 on RNA-Based Biomarkers to Predict Immunotherapy Response
The Xerna TME panel identified nearly 50 percent of [...]
Prevalence of genomic alterations in Xerna tumor microenvironment subtypes in colorectal cancer patients
This study explores the distribution of genomic alterations in [...]
Profiling microsatellite instability using RNA sequencing data
This study introduces a machine learning model that uses [...]
